LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
1
 56.45 27.76 1551 5745 0.2700 0.6870
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 56.45 27.76 1878 5745 0.3269 0.7295
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 58.15 27.76 1203 5906 0.2037 0.6280
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 58.15 27.76 1642 5906 0.2780 0.6949
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 58.15 27.76 1419 5906 0.2402 0.6632
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 58.15 27.76 1905 5906 0.3225 0.7278
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 59.85 27.76 1091 6062 0.1800 0.6039
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 59.85 27.76 1684 6062 0.2778 0.6961
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 59.85 27.76 1335 6062 0.2202 0.6461
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 59.85 27.76 1969 6062 0.3248 0.7305
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 61.56 27.76 1072 6217 0.1724 0.5968
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 61.56 27.76 1716 6217 0.2760 0.6960
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 61.56 27.76 1216 6217 0.1956 0.6228
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 61.56 27.76 2047 6217 0.3293 0.7347
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 63.26 27.76 959 6465 0.1483 0.5691
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 63.26 27.76 1739 6465 0.2690 0.6924
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 63.26 27.76 1202 6465 0.1859 0.6148
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 63.26 27.76 2090 6465 0.3233 0.7324
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 64.97 27.76 853 6656 0.1281 0.5423
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 64.97 27.76 1794 6656 0.2695 0.6943
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 64.97 27.76 1113 6656 0.1672 0.5951
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 64.97 27.76 2159 6656 0.3243 0.7345
MN20160318_Q01
G04
MCF 10A-H2B-mCherry Dasatinib
1
 66.67 27.76 815 6695 0.1217 0.5327
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 66.67 27.76 1870 6695 0.2793 0.7023
MN20160318_Q01
E05
MCF 10A-H2B-mCherry Dasatinib
1
 66.67 27.76 1074 6695 0.1604 0.5871
MN20160318_Q01
G04